ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print March 26, 2009, 10.1183/09031936.00006508
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/3/731    most recent
09031936.00006508v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Le Pavec, J.
Right arrow Articles by Herve, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Pavec, J.
Right arrow Articles by Herve, P.
Eur Respir J 2009; 34:731-739
Copyright ©ERS Journals Ltd 2009

Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats

J. Le Pavec1, F. Perros1, S. Eddahibi2, B. Decante1, P. Dorfmuller1, O. Sitbon1, D. Lebrec3, M. Humbert1, M. Mazmanian1 and P. Herve1

1 Laboratoire de Chirurgie Expérimentale-UPRES (EA-2705), Hopital Marie Lannelongue, Université Paris Sud, Le Plessis Robinson, 2 INSERM U492, Hopital Henri Mondor, Créteil, and 3 Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U481, Hopital Beaujon, Clichy, France.

CORRESPONDENCE: P. Herve, Centre Chirurgical Marie Lannelongue, 133 Avenue de la Résistance, 92350 Le Plessis Robinson, France. E-mail: pherve{at}ccml.com

Keywords: Endothelin, inflammation, macrophages, nitric oxide

Received: January 15, 2008
Accepted March 12, 2009

Common bile duct ligation (CBDL) induces biliary cirrhosis and pulmonary vasodilatation. We tested whether CBDL ameliorates monocrotaline (MCT)-induced pulmonary hypertension (PH) in rats.

Five groups of rats were studied: controls; rats dosed with MCT (60 mg·kg–1 subcutaneously); CBDL; rats dosed with MCT followed by CBDL on day 7; and rats dosed with MCT followed by CBDL (day 7) and L-NAME therapy between days 24 and 28. 28-day survival was 26% in the MCT group and 72% in the MCT+CBDL group. Pulmonary vascular resistance measured on days 21 and 28 increased in the MCT and MCT+CBDL+L-NAME groups, but returned to normal in the MCT+CBDL group on day 28. Pulmonary artery (PA) medial hypertrophy persisted in MCT+CBDL rats. PA inflammation increased in MCT+CBDL rats, with accumulation of both intra- and perivascular macrophages. Exhaled nitric oxide (NO) levels decreased in the MCT group and increased in the MCT+CBDL group, which showed upregulation of inducible NO synthase and normal endothelial NO synthase. Blood endothelin (ET)-1 increased in CBDL, MCT, and MCT+CBDL rats. Levels of ETB receptors increased and ETA receptors decreased in the MCT+CBDL group, whereas the opposite changes occurred in the MCT group.

Biliary cirrhosis induces pulmonary vasodilation that ameliorates MCT-induced PH and improves survival. Upregulation of inducible NO synthase and ETB receptor and downregulation of ETA receptor may be involved.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.